Header Logo

Connection

SARAH WHEELER to Myeloablative Agonists

Back to Details
This is a "connection" page, showing publications SARAH WHEELER has written about Myeloablative Agonists.
SARAH WHEELER
Connection Strength
0.035
Myeloablative Agonists
  1. Pharmacokinetic and clinical outcomes when ideal body weight is used to dose busulfan in obese hematopoietic stem cell transplant recipients. Bone Marrow Transplant. 2019 02; 54(2):218-225.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.